Which neurological disorders respond to 3,4 diaminopyridine?

Aminopyridines for the treatment of neurologic disorders

Strupp M, Teufel J, Zwergal A, Schniepp R, Khodakhah K, Feil K.

Neurol Clin Pract 2017; 7:65-76


Purpose of review:

To identify the different indications for the treatment of neurologic disorders with the potassium channel blockers 4-aminopyridine (4-AP) and 3,4-diaminopyridine (3,4-DAP).

Recent findings:

4-AP is an effective symptomatic treatment for downbeat nystagmus (DBN), episodic ataxia type 2 (EA2) (5–10 mg TID), and impaired gait in multiple sclerosis (MS) (10 mg BID). 3,4-DAP (5 mg/d–20 mg TID) improves symptoms in Lambert-Eaton myasthenic syndrome (LEMS) (randomized placebo-controlled trials for all 4 entities). 4-AP may also be effective in cerebellar gait ataxia of different etiologies (2 case series), upbeat nystagmus, and limb ataxia in MS (single cases). In the recommended dosages, they are well tolerated. The assumed mode of action is a blockade of mainly Kv1.5: in DBN, this increases the excitability of Purkinje cells (PC), and in EA2, restores the precision of resting discharge of PC. In MS, 4-AP improves the conduction of action potentials in demyelinated axons, and in LEMS, 3,4-DAP facilitates the transmission at the neuromuscular endplate by prolonging the action potential duration.


There is sufficient evidence that aminopyridines are indicated for the symptomatic treatment of downbeat nystagmus (DBN), episodic ataxia type 2 (EA2), gait ataxia due to MS and cerebellar disorders, and Lambert Eaton myasthenic syndrome (LEMS) with a reasonable risk-benefit profile.


This paper is cited in the neurocheklist:

3,4 diaminopyridine (3,4 DAP)

Abstract link

由无法识别作者。根据版权声明推断作者为Osnimf。 – 无法识别来源。根据版权声明推断为其自己的作品。,公有领域,https://commons.wikimedia.org/w/index.php?curid=399659

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s